Table 1. Open in new tab Patient and...

Variable

All patients (n = 200), n (%)

Alive from hospital (n = 118), n (%)

Death at hospital (n = 82), n (%)

p value

Age, yr

59.8 ± 11.4

60.3 ± 11.3

58.5 ± 12.7

.22

Sex

Female

71 (38.7)

44 (37.3)

27 (32.9)

.53

Male

129 (64.5)

74 (62.7)

55 (67.1)

Duration of metastatic disease, mo

≤ 7

101 (50.5)

47 (39.8)

54 (65.9)

.0003

> 7

99 (49.5)

71 (60.2)

28 (34.1)

Admission SOFA score

Missing

14 (7)

≤ 5

80 (40)

61 (53.5)

19 (26.4)

<.0001

6 to 10

72 (36)

44 (38.6)

28 (38.9)

> 10

34 (17)

9 (7.9)

25 (34.7)

Tumor type

Intestinal

75 (37.5)

51 (43.2)

24 (29.3)

.03

Hepatobiliary/pancreatic

72 (36)

44 (37.3)

28 (34.1)

Gastroesophageal

48 (24)

20 (16.9)

28 (34.1)

Unknown primary

5 (2.5)

3 (2.5)

2 (2.4)

Grade

Missing

32 (16)

Well or moderate

76 (38)

57 (58.2)

19 (27.1)

.001

Poor

92 (46)

41 (41.8)

51 (72.9)

Number of metastatic sites

Missing

4 (2)

0 to 2

139 (69.5)

82 (70.7)

57 (71.3)

.93

≥ 3

57 (28.5)

34 (29.3)

23 (28.8)

Code status at ICU admission

Missing

1 (0.5)

Do not resuscitate

32 (16)

11 (9.4)

21 (25.6)

.002

Full

167 (83.5)

106 (90.6)

61 (74.4)

Chemotherapy status

On treatment

126 (63)

76 (64.4)

50 (61)

.002

Off treatment

Treatment completed

38 (19)

29 (24.6)

9 (11)

Poor performance status

36 (18)

13 (11)

23 (28)

Table 1.

Open in new tab

Patient and clinical characteristics for all patients and by hospital survival status

Variable	All patients (n = 200), n (%)	Alive from hospital (n = 118), n (%)	Death at hospital (n = 82), n (%)	p value
Age, yr	59.8 ± 11.4	60.3 ± 11.3	58.5 ± 12.7	.22
Sex
Female	71 (38.7)	44 (37.3)	27 (32.9)	.53
Male	129 (64.5)	74 (62.7)	55 (67.1)
Duration of metastatic disease, mo
≤ 7	101 (50.5)	47 (39.8)	54 (65.9)	.0003
> 7	99 (49.5)	71 (60.2)	28 (34.1)
Admission SOFA score
Missing	14 (7)
≤ 5	80 (40)	61 (53.5)	19 (26.4)	<.0001
6 to 10	72 (36)	44 (38.6)	28 (38.9)
> 10	34 (17)	9 (7.9)	25 (34.7)
Tumor type
Intestinal	75 (37.5)	51 (43.2)	24 (29.3)	.03
Hepatobiliary/pancreatic	72 (36)	44 (37.3)	28 (34.1)
Gastroesophageal	48 (24)	20 (16.9)	28 (34.1)
Unknown primary	5 (2.5)	3 (2.5)	2 (2.4)
Grade
Missing	32 (16)
Well or moderate	76 (38)	57 (58.2)	19 (27.1)	.001
Poor	92 (46)	41 (41.8)	51 (72.9)
Number of metastatic sites
Missing	4 (2)
0 to 2	139 (69.5)	82 (70.7)	57 (71.3)	.93
≥ 3	57 (28.5)	34 (29.3)	23 (28.8)
Code status at ICU admission
Missing	1 (0.5)
Do not resuscitate	32 (16)	11 (9.4)	21 (25.6)	.002
Full	167 (83.5)	106 (90.6)	61 (74.4)
Chemotherapy status
On treatment	126 (63)	76 (64.4)	50 (61)	.002
Off treatment
Treatment completed	38 (19)	29 (24.6)	9 (11)
Poor performance status	36 (18)	13 (11)	23 (28)

Variable	All patients (n = 200), n (%)	Alive from hospital (n = 118), n (%)	Death at hospital (n = 82), n (%)	p value
Age, yr	59.8 ± 11.4	60.3 ± 11.3	58.5 ± 12.7	.22
Sex
Female	71 (38.7)	44 (37.3)	27 (32.9)	.53
Male	129 (64.5)	74 (62.7)	55 (67.1)
Duration of metastatic disease, mo
≤ 7	101 (50.5)	47 (39.8)	54 (65.9)	.0003
> 7	99 (49.5)	71 (60.2)	28 (34.1)
Admission SOFA score
Missing	14 (7)
≤ 5	80 (40)	61 (53.5)	19 (26.4)	<.0001
6 to 10	72 (36)	44 (38.6)	28 (38.9)
> 10	34 (17)	9 (7.9)	25 (34.7)
Tumor type
Intestinal	75 (37.5)	51 (43.2)	24 (29.3)	.03
Hepatobiliary/pancreatic	72 (36)	44 (37.3)	28 (34.1)
Gastroesophageal	48 (24)	20 (16.9)	28 (34.1)
Unknown primary	5 (2.5)	3 (2.5)	2 (2.4)
Grade
Missing	32 (16)
Well or moderate	76 (38)	57 (58.2)	19 (27.1)	.001
Poor	92 (46)	41 (41.8)	51 (72.9)
Number of metastatic sites
Missing	4 (2)
0 to 2	139 (69.5)	82 (70.7)	57 (71.3)	.93
≥ 3	57 (28.5)	34 (29.3)	23 (28.8)
Code status at ICU admission
Missing	1 (0.5)
Do not resuscitate	32 (16)	11 (9.4)	21 (25.6)	.002
Full	167 (83.5)	106 (90.6)	61 (74.4)
Chemotherapy status
On treatment	126 (63)	76 (64.4)	50 (61)	.002
Off treatment
Treatment completed	38 (19)	29 (24.6)	9 (11)
Poor performance status	36 (18)	13 (11)	23 (28)

Intestinal tumor type included 65 colorectal and 10 small bowel.

Hepatobiliary tumor type included 41 pancreas, 14 hepatocellular, and 17 biliary.

Abbreviations: ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment.

This Feature Is Available To Subscribers Only